000 | 01837 a2200505 4500 | ||
---|---|---|---|
005 | 20250517055527.0 | ||
264 | 0 | _c20160525 | |
008 | 201605s 0 0 eng d | ||
022 | _a1879-1301 | ||
024 | 7 |
_a10.1016/j.chembiol.2015.08.013 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBadarau, Eduard | |
245 | 0 | 0 |
_aDevelopment of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions. _h[electronic resource] |
260 |
_bChemistry & biology _cOct 2015 |
||
300 |
_a1347-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xchemistry |
650 | 0 | 4 |
_aFibrosis _xdrug therapy |
650 | 0 | 4 |
_aGTP-Binding Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMicroscopy, Fluorescence |
650 | 0 | 4 | _aNIH 3T3 Cells |
650 | 0 | 4 |
_aNephrosclerosis _xdrug therapy |
650 | 0 | 4 |
_aProtein Binding _xdrug effects |
650 | 0 | 4 | _aProtein Glutamine gamma Glutamyltransferase 2 |
650 | 0 | 4 |
_aSmall Molecule Libraries _xchemistry |
650 | 0 | 4 |
_aSyndecan-4 _xmetabolism |
650 | 0 | 4 |
_aTransglutaminases _xantagonists & inhibitors |
700 | 1 | _aWang, Zhuo | |
700 | 1 | _aRathbone, Dan L | |
700 | 1 | _aCostanzi, Andrea | |
700 | 1 | _aThibault, Thomas | |
700 | 1 | _aMurdoch, Colin E | |
700 | 1 | _aEl Alaoui, Said | |
700 | 1 | _aBartkeviciute, Milda | |
700 | 1 | _aGriffin, Martin | |
773 | 0 |
_tChemistry & biology _gvol. 22 _gno. 10 _gp. 1347-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.chembiol.2015.08.013 _zAvailable from publisher's website |
999 |
_c25344201 _d25344201 |